Variation of blood T lymphocyte subgroups in patients with non- small cell lung cancer

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 8, 2013, Pages 4671-4673

  Wang, Wen Jing ^a   Tao, Zhen ^a   Gu, Wei ^a   Sun, Li Hua ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Cellular immune; Flow cytometry; Lymphocyte subset; Non small cell lung cancer

Indexed keywords

CD3 ANTIGEN;

ADULT; AGED; ARTICLE; BLOOD; CANCER STAGING; CASE CONTROL STUDY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; COMPARATIVE STUDY; FEMALE; FLOW CYTOMETRY; FOLLOW UP; HUMAN; IMMUNOLOGY; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MALE; METABOLISM; MIDDLE AGED; NATURAL KILLER CELL; PATHOLOGY; PROGNOSIS; REGULATORY T LYMPHOCYTE;

ADULT; AGED; ANTIGENS, CD3; CARCINOMA, NON-SMALL-CELL LUNG; CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; FLOW CYTOMETRY; FOLLOW-UP STUDIES; HUMANS; KILLER CELLS, NATURAL; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; T-LYMPHOCYTES, REGULATORY;

EID: 84885718584     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.8.4671     Document Type: Article

References (15)

1. Dou X, Wang RB, Yan HJ, et al (2013). Circulating lymphocytes as predictors of sensitivity to preoperative chemoradiotherapy in rectal cancer cases. Asian Pac J Cancer Prev, 14, 3881-5.
2. Erdem MG, Cinkilic N, Vatan O, et al (2012). Genotoxic and anti-genotoxic effects of vanillic acid against mitomycin C-induced genomic damage in human lymphocytes in vitro.Asian Pac J Cancer Prev, 13, 4993-8.
3. Hakansson A, Hakansson L, Gustaffisson B, et al (2003). On the effect of biochemotherapy in metastatic malignant melanoma: an unopathological evaluation. Melanoma Res, 13, 401-8.
4. Hanaki K, Momo A, Oku T, et al (2003). Semiconductor quantum dot/albumin complex is a long-life and highly photostable endosome marker. Biochem Biophys Res Commun, 302, 496-501.
5. Jason D, Marc A, Alexander Y, et al (2003). Foxp3 programs the development and function of CD4+ CD25+ regulatory T cells. Nature Immuno, 4, 330-6.
6. Karaman H, Karaman A, Erden A, et al (2013). Relationship between colonic polyp type and the neutrophil/ lymphocyte ratio as a biomarker. Asian Pac J Cancer Prev, 14, 3159-61.
7. Liu YC, Zhou SB, Gao F, et al (2013). Chemotherapy and late course three dimensional conformal radiotherapy for treatment of patients with stage III non-small cell lung cancer. Asian Pac J Cancer Prev, 14, 2663-5.
8. Lu YY, Huang XE, Xu L, et al (2013). Potential predictors of sensitivity to pemetrexed as first-line chemotherapy for patients with advanced non-squamous NSCLCs. Asian Pac J Cancer Prev, 14, 2005-8.
9. Manni JA, Guilleron C, Araujo HA, et al (1989). Lymphocyte imbalance in autoimmunity. Medicina B Aires, 49, 105-8.
10. Mattes J, Hulett M, Xie W, et al (2003). Immunotherapy of cytotoxic T cell resist ant tumors by T helper 2 cells: an eot axin and AT dependent process. J Exp Med, 197, 387-93.
11. Mitropoulos D, Alamanis C, Deliveliotts C, et al (1995).T-lymphocyt e subgoups in the peripheral blood of patients with renal cell carcinoma. Arta Urol Belg, 63, 21-5.
12. Nakamura H, Kawasaki N, Hagiwara M, et al (2000). Cellular immunologic parameters related to age, gender, and stage in lung cancer patients. Lung Cancer, 28, 139-45.
13. Nugroho AE, Hermawan A, Nastiti K, (2012). Immunomodulatory effects of hexane insoluble fraction of Ficus septica Burm. F. in doxorubicin-treated rats. Asian Pac J Cancer Prev, 13, 5785-90.
14. Parkin DM, Brary FB, Pisani P (2005). Global cancer statistics. Cancer J Clin, 55, 74-108.
15. Wing K, Lindgren S, Kollberg G, et al (2003). CD4+ T cell activation by myelinoligodendrocyte glycoprot ein is suppressed by adult but not cord blood CD4+ T cells. Eur J Immunol, 33, 579-87.